Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1981-04-06
1983-07-19
Rosen, Sam
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424180, A61K 3160, A61K 3556
Patent
active
043943730
ABSTRACT:
The method of achieving hemostasis in wounds, vascular grafts, vascular patches, cardiac valves and the like is described. Hemostasis is achieved in open wounds by topically administering chitosan, in liquid or powder form, to the wound. Hemostasis is achieved in vascular grafts, vascular patches, cardiac valves and areas to be sutured by either topically administering chitosan to the grafts, patches, valves and sutures or incorporating chitosan in the material of the grafts, patches, valves and sutures.
REFERENCES:
patent: 3903268 (1975-09-01), Balassa
patent: 3911116 (1975-10-01), Balassa
patent: 3914414 (1975-10-01), Balassa
The Merck Index, 9th Ed., Pub. by Merck & Co. Inc., N.J., 1976, p. 259.
Malette William G.
Quigley, Jr. Herbert J.
LandOfFree
Method of achieving hemostasis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of achieving hemostasis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of achieving hemostasis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-751353